Read More

Autonomix Announces The Completion Of Its Site Initiation For Its Proof-Of-Concept Human Clinical Study Evaluating The Use Of Transvascular RF Ablation For The Treatment Of Pancreatic Cancer Pain

Site initiation completed for first study ever to evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancerTHE WOODLANDS, TX, Feb. 16, 2024 (GLOBE NEWSWIRE) --

AMIX

Read More

Alnylam Earlier Announced Updates To The Statistical Analysis Plan For The HELIOS-B Phase 3 Study Of Vutrisiran; Will Include Updates To The Primary And Secondary Endpoint Structure; Topline Results Are Expected To Be Available In Late June Or Early Ju…

R&D HighlightsAlnylam announces today updates to the statistical analysis plan for the HELIOS-B Phase 3 study of vutrisiran in patients with ATTR amyloidosis with cardiomyopathy. These will include updates to the

ALNY